21 related articles for article (PubMed ID: 15646818)
1. Correction to "Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide".
Biotechnol Prog; 2024 May; ():e3455. PubMed ID: 38801176
[No Abstract] [Full Text] [Related]
2. Role of Nasal Fibroblasts in Airway Remodeling of Chronic Rhinosinusitis: The Modulating Functions Reexamined.
Shin JM; Yang HW; Park JH; Kim TH
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835423
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis].
Klimek L; Högger P; Pfaar O
HNO; 2012 Jul; 60(7):611-7. PubMed ID: 22532281
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyproline levels in nasal polyps.
Cincik H; Kapucu B; Ipcioglu OM; Gungor A; Dursun E
Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1147-1150. PubMed ID: 21365211
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis.
Okano M
Clin Exp Immunol; 2009 Nov; 158(2):164-73. PubMed ID: 19737138
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of glucocorticoids in nasal polyposis.
Fernandes AM; Valera FC; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2008; 74(2):279-83. PubMed ID: 18568209
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury.
Tsuchihashi S; Ke B; Kaldas F; Flynn E; Busuttil RW; Briscoe DM; Kupiec-Weglinski JW
Am J Pathol; 2006 Feb; 168(2):695-705. PubMed ID: 16436682
[TBL] [Abstract][Full Text] [Related]
8. Influence of fluticasone propionate on the production of vascular endothelial growth factor and basic fibroblast growth factor from nasal fibroblasts in vitro.
Uchida J; Kanai K; Asano K; Watanabe S; Hisamitsu T; Suzaki H
In Vivo; 2004; 18(6):767-70. PubMed ID: 15646818
[TBL] [Abstract][Full Text] [Related]
9. Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro.
Namba M; Asano K; Kanai K; Kyo Y; Watanabe S; Hisamitsu T; Suzaki H
Acta Otolaryngol; 2004 Oct; 124(8):964-9. PubMed ID: 15513534
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis.
Lin SK; Shun CT; Kok SH; Wang CC; Hsiao TY; Liu CM
Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):522-7. PubMed ID: 18490575
[TBL] [Abstract][Full Text] [Related]
11. [Generation of tumor necrosis factor alpha by human nasal epithelial cells and inhibition by fluticasone propionate].
Ohnishi M; Takizawa R; Yokoshima K; Okubo K; Okuda M; Yagi T
Arerugi; 1995 Oct; 44(10):1216-22. PubMed ID: 8579483
[TBL] [Abstract][Full Text] [Related]
12. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling.
Silvestri M; Sabatini F; Scarso L; Cordone A; Dasic G; Rossi GA
Int Arch Allergy Immunol; 2002 May; 128(1):51-8. PubMed ID: 12037401
[TBL] [Abstract][Full Text] [Related]
13. The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate.
Serpero L; Petecchia L; Sabatini F; Giuliani M; Silvestri M; Di Blasi P; Rossi GA
Immunol Lett; 2006 May; 105(1):61-7. PubMed ID: 16481045
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
